Average light intensity determined that CD4 CAR T cell-treated mice had a 52% lower tumor burden relative to control on Day 6, whereas CD4-IL15/IL15sushi CAR T cells had a 74% lower tumor burden (Figure 2B). This evidence concerns the gene CD4 and neoplasm.